JAK-STAT Signaling Pathway

Overview & Components - Pathway Kickstart

• JAK-STAT Pathway: Rapid signal transduction from cell-surface receptors to nucleus, regulating gene expression. Vital for immunity, growth, hematopoiesis.
• Key Ligands:
  • Cytokines: Interferons (IFNs), Interleukins (ILs)
  • Hormones: Growth Hormone (GH), Prolactin (PRL), Erythropoietin (EPO), Thrombopoietin (TPO), Leptin
• Receptors: Type I & II cytokine receptors; lack intrinsic kinase activity.
• JAKs (Janus Kinases): Cytoplasmic tyrosine kinases (JAK1, JAK2, JAK3, TYK2) associated with receptor tails.

  ⭐ JAKs are non-receptor tyrosine kinases that constitutively associate with the cytoplasmic tails of cytokine receptors.

• STATs (Signal Transducers and Activators of Transcription): Latent cytoplasmic transcription factors (STAT1-6; STAT5a/b) with SH2 domains for phosphotyrosine binding.
• 📌 Mnemonic: Cytokines Just Ask Kindly for STATus reports.

Mechanism of Action - Signal Relayers

📌 Mnemonic: "Lazy Dogs Really Sit, Sleep, Dream, Nap, Go." (Ligand, Dimerization, JAKs, Receptor, STATs, STAT Dimerization, Nuclear translocation, Gene transcription)

• 1. Ligand Binding & Receptor Dimerization: Cytokine binding induces receptor dimerization.
• 2. JAK Activation: Dimerization brings receptor-associated JAKs (Janus Kinases) close; they trans-phosphorylate and activate each other.
• 3. Receptor Phosphorylation: Activated JAKs phosphorylate tyrosine residues on receptor tails, creating docking sites.
• 4. STAT Recruitment: STAT (Signal Transducers and Activators of Transcription) proteins, via their SH2 domains, bind to these phosphotyrosine sites on the receptor.
• 5. STAT Phosphorylation: Receptor-bound STATs are phosphorylated by JAKs on a critical C-terminal tyrosine residue.
• 6. STAT Dimerization: Phosphorylated STATs dissociate from the receptor and form homo- or heterodimers via reciprocal SH2 domain-phosphotyrosine interactions.
• 7. Nuclear Translocation: STAT dimers translocate into the nucleus (e.g., via the importin system).
• 8. DNA Binding: In the nucleus, STAT dimers bind to specific DNA sequences (e.g., GAS - Gamma Interferon Activated Sequence; ISRE - Interferon-Stimulated Response Element) in gene promoters.
• 9. Gene Transcription Activation: Bound STAT dimers recruit co-activators, initiating transcription of target genes.

⭐ The SH2 domain of STAT proteins is critical for both their recruitment to phosphorylated receptors and for STAT dimerization.

Regulation & Functions - Pathway Police

Negative Regulators:

Physiological Functions:

• Immune responses: IFN signaling, T/B cell development, NK cell function.
• Hematopoiesis: Erythropoietin (EPO) $ ightarrow$ JAK2-STAT5; Thrombopoietin (TPO) $ ightarrow$ JAK2-STAT3/5.
• Inflammation, cell growth, differentiation, apoptosis.

⭐ SOCS proteins are themselves transcriptionally upregulated by STATs, forming a classical negative feedback loop to terminate cytokine signaling.

Clinical Significance - Signals Go Rogue

Dysregulation leads to:

• Immunodeficiency: JAK3 mutations → SCID (T⁻B⁺NK⁻).
• Autoimmune Diseases: RA, Psoriasis, IBD (↑JAKs).
• Cancers:
  • Myeloproliferative Neoplasms (MPNs): JAK2 V617F in PV, ET, PMF.
  • Leukemia, Lymphoma.

⭐ The JAK2 V617F gain-of-function mutation is a major diagnostic marker for myeloproliferative neoplasms, leading to constitutive activation of the JAK-STAT pathway.

Therapeutic Targeting: JAK inhibitors (JAKinibs). 📌 JAKinibs NIBble at overactive JAKs.

• Examples:
  • Tofacitinib (JAK1/3; RA, PsA, UC)
  • Ruxolitinib (JAK1/2; MPNs)
  • Baricitinib (JAK1/2; RA)
  • Upadacitinib (JAK1; RA, PsA, IBD)

High‑Yield Points - ⚡ Biggest Takeaways

• JAKs: Non-receptor tyrosine kinases linked to cytokine receptors (Type I/II).
• STATs: Latent cytoplasmic transcription factors; translocate to nucleus when activated.
• Activation: Ligand → Receptor dimerization → JAK autophosphorylation & STAT phosphorylation.
• Gene Regulation: Phospho-STATs dimerize, enter nucleus, bind DNA (e.g., GAS elements).
• Key Roles: Hematopoiesis, immune response (IFN signaling), inflammation, growth.
• Inhibition: SOCS proteins and PTPs provide crucial negative feedback.
• Pathology: Implicated in immunodeficiencies, myeloproliferative neoplasms, autoimmune diseases.